L-4FPG
CAS No. 19883-57-9
L-4FPG( 4-Fluoro-L-Phenylglycine | 4-Fluorophenylglycine )
Catalog No. M27369 CAS No. 19883-57-9
L-4FPG inhibits the neutral amino acid transporters ASCT1 and ASCT2. It also shows good brain penetration and potently reduces amphetamine-induced hyperlocomotion.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameL-4FPG
-
NoteResearch use only, not for human use.
-
Brief DescriptionL-4FPG inhibits the neutral amino acid transporters ASCT1 and ASCT2. It also shows good brain penetration and potently reduces amphetamine-induced hyperlocomotion.
-
DescriptionL-4FPG inhibits the neutral amino acid transporters ASCT1 and ASCT2. It also shows good brain penetration and potently reduces amphetamine-induced hyperlocomotion.
-
In VitroAmino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances.
-
In Vivo——
-
Synonyms4-Fluoro-L-Phenylglycine | 4-Fluorophenylglycine
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number19883-57-9
-
Formula Weight169.155
-
Molecular FormulaC8H8FNO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 1.96 mg/mL (11.59 mM)
-
SMILESN[C@H](C(O)=O)c1ccc(F)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Loquais Y, Gloaguen E, Alauddin M, Brenner V, Tardivel B, Mons M. On the near UV photophysics of a phenylalanine residue: conformation-dependent ππ* state deactivation revealed by laser spectroscopy of isolated neutral dipeptides. Phys Chem Chem Phys. 2014 Oct 28;16(40):22192-200. doi: 10.1039/c4cp03401e. Epub 2014 Sep 12. PubMed PMID: 25213197.
molnova catalog
related products
-
Vonlerolizumab
Vonlerolizumab(MOXR 0916) is a humanized IgG agonistic OX40-specific monoclonal antibody with potential antitumor activity for the study of tumors and immune diseases.
-
Phillygenin
Phillyrin, (+)-Phillygenin, and (-)-phillygenin exert the strongest inhibitory activities on NO production with IC(5) values.
-
IMR-1A
IMR-1A is the metabolite of IMR-1 which is a novel class of Notch inhibitors targeting the transcriptional activation with IC50 of 6 μMol/L.
Cart
sales@molnova.com